AI assistant
Pfizer Ltd. — Regulatory Filings 2022
Jun 30, 2022
60507_rns_2022-06-30_dcc90766-4de4-4eff-a600-f5da52328d18.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Pfizer Limited
==> picture [100 x 41] intentionally omitted <==
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
June 30, 2022
The Corporate Relationship Dept. BSE Limited 1[st] Floor, P.J.Towers Dalal Street, Fort Mumbai – 400 001 Scrip Code: 500680
The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Closure of Trading Window - Pfizer Limited
We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company, for the quarter ended June 30, 2022, the trading window of the Company shall remain closed from Thursday, June 30, 2022 (close of business) till 48 hours after the results are made public.
We request you to kindly take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited
==> picture [117 x 45] intentionally omitted <==
Prajeet Nair Company Secretary
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerindia.com